Nutraceutical and phytotherapy supplementation in the treatment of fibromyalgia: literature review
DOI:
https://doi.org/10.33448/rsd-v10i14.12381Keywords:
Fibromyalgia; Dietary supplement; Nutraceutical; Oxidative stress.Abstract
Fibromyalgia (FB) is a multifactorial disease that affects a large portion of the population and still has its diagnosis as a subject of controversy. It is characterized by chronic pain in multiple points of the body. This article aimed to identify nutraceutical supplements that could contribute to the treatment of FB in its multiple aspects and thus improve the quality of life of the patients. The bibliographic survey was limited to searches for articles in Portuguese and English in the PubMed, SciELO and LILACS databases published between January 2015 and March 2020. The most commonly found active ingredients were coenzyme Q10, 25-hydroxyvitamin D, probiotics (Lactobacillus Rhamnosus, Casei, Acidophilus and Bifidobacterium Bifidus) and phytotherapic medicines such as ginger, acerola cherry, Spiraea Ulmaria, passiflora, Elymus repens in association with other products, Crocus Sativus (saffron) and also Ganoderma lucidum, a kind of mushroom. It is of fundamental importance to understand how supplements can help in the treatment of fibromyalgia, promoting a more natural therapy, less expensive and with less side effects for its patients.
References
Arora, D. (1986). Mushrooms Demystified: A Comprehensive Guide to the Fleshy Fungi. Ten Speed Press.
Barmaki, M., Maindet-Dominici, C., Nizard, J., Baron, D., Russ, I., Fardellone, P., … Bertin, P. (2019). Multicenter, Prospective, Controlled Double-Blind Study Comparing Fib-19-01, A Phytotherapy Treatment, To A Dietary Supplement And To Conventional Care In Patients Suffering From Fibromyalgia. Alternative Therapies in Health and Medicine, 25(4), 46–53.
Binkiewicz-Glinska, A., Bakula, S., Tomczak, H., Landowski, J., Ruckemann-Dziurdzinska, K., Zaborowska-Sapeta, K., & Kiebzak, W. (2015). Fibromyalgia Syndrome - a multidisciplinary approach. Psychiatria Polska, 49(4), 801–810. https://doi.org/10.12740/psychiatriapolska.pl/online-first/4
Collado Mateo, D., Pazzi, F., Dominguez Munoz, F. J., Martin Martinez, J. P., Olivares, P. R., Gusi, N., & Adsuar, J. C. (2015). Ganoderma Lucidum Improves Physical Fitness In Women With Fibromyalgia. Nutricion Hospitalaria, 32(5), 2126–2135. https://doi.org/10.3 305/nh.2015.32.5.9601
Cordero, M. D., Alcocer-Gómez, E., de Miguel, M., Cano-García, F. J., Luque, C. M., Fernández-Riejo, P., & Sánchez-Alcazar, J. A. (2011). Coenzyme Q(10): a novel therapeutic approach for Fibromyalgia? case series with 5 patients. Mitochondrion, 11(4), 623–625. https://doi.org/10.1016/j.mito.2011.03.122
Cordero, M. D., de Miguel, M., Carmona-López, I., Bonal, P., Campa, F., & Moreno-Fernández, A. M. (2010). Oxidative stress and mitochondrial dysfunction in fibromyalgia. Neuro Endocrinology Letters, 31(2), 169–173.
de Carvalho, J. F., da Rocha Araujo, F. A. G., da Mota, L. M. A., Aires, R. B., & de Araujo, R. P. (2018). Vitamin D Supplementation Seems to Improve Fibromyalgia Symptoms: Preliminary Results. The Israel Medical Association Journal : IMAJ, 20(6), 379–381.
Di Pierro, F., Rossi, A., Consensi, A., Giacomelli, C., & Bazzichi, L. (2017). Role for a water-soluble form of CoQ10 in female subjects affected by fibromyalgia. A preliminary study. Clinical and Experimental Rheumatology, 35 Suppl 1(3), 20–27.
Dinan, T. G., & Quigley, E. M. (2011, December). Probiotics in the treatment of depression: science or science fiction? The Australian and New Zealand Journal of Psychiatry. England. https://doi.org/10.3109/00048674.2011.613766
Ellis, S. D., Kelly, S. T., Shurlock, J. H., & Hepburn, A. L. N. (2018). The role of vitamin D testing and replacement in fibromyalgia: a systematic literature review. BMC Rheumatology, 2, 28. https://doi.org/10.1186/s41927-018-0035-6
Häuser, W., Ablin, J., Fitzcharles, M.-A., Littlejohn, G., Luciano, J. V, Usui, C., & Walitt, B. (2015). Fibromyalgia. Nature Reviews. Disease Primers, 1, 15022. https://doi.org/10.1038/nrdp.2015.22
Hauser, W., Sarzi-Puttini, P., & Fitzcharles, M.-A. (2019). Fibromyalgia syndrome: under-, over- and misdiagnosis. Clinical and Experimental Rheumatology, 37 Suppl 1(1), 90–97.
Jorat, M. V., Tabrizi, R., Kolahdooz, F., Akbari, M., Salami, M., Heydari, S. T., & Asemi, Z. (2019, April 1). The effects of coenzyme Q10 supplementation on biomarkers of inflammation and oxidative stress in among coronary artery disease: a systematic review and meta-analysis of randomized controlled trials. Inflammopharmacology. Birkhauser Verlag AG. https://doi.org/10.1007/s10787-019-00572-x
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., & Moher, D. (2009). The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Medicine, 6(7), e1000100. https://doi.org/10.1371/journal.pmed.1000100
Martins, Y. A., Cardinali, C. A. E. F., Ravanelli, M. I., & Brunaldi, K. (2020). Is hypovitaminosis D associated with fibromyalgia? A systematic review. Nutrition Reviews, 78(2), 115–133. https://doi.org/10.1093/nutrit/nuz033
Mazidi, M., Shemshian, M., Mousavi, S. H., Norouzy, A., Kermani, T., Moghiman, T., & Ferns, G. A. A. (2016). A double-blind, randomized and placebo-controlled trial of Saffron (Crocus sativus L.) in the treatment of anxiety and depression. Journal of Complementary & Integrative Medicine, 13(2), 195–199. https://doi.org/10.1515/jcim-2015-0043
Mirzaei, A., Zabihiyeganeh, M., Jahed, S. A., Khiabani, E., Nojomi, M., & Ghaffari, S. (2018). Effects of vitamin D optimization on quality of life of patients with fibromyalgia: A randomized controlled trial. Medical Journal of the Islamic Republic of Iran, 32, 29. https://doi.org/10.14196/mjiri.32.29
Mizobuti, D. S., Fogaça, A. R., Moraes, F. dos S. R., Moraes, L. H. R., Mâncio, R. D., Hermes, T. de A., & Minatel, E. (2019). Coenzyme Q10 supplementation acts as antioxidant on dystrophic muscle cells. Cell Stress and Chaperones, 24(6), 1175–1185. https://doi.org/10.1007/s12192-019-01039-2
Mousavinejad, E., Ghaffari, M. A., Riahi, F., Hajmohammadi, M., Tiznobeyk, Z., & Mousavinejad, M. (2018). Coenzyme Q10 supplementation reduces oxidative stress and decreases antioxidant enzyme activity in children with autism spectrum disorders. Psychiatry Research, 265, 62–69. https://doi.org/10.1016/j.psychres.2018.03.061
Pereira A.S. et al. (2018). Metodologia da pesquisa científica. UFSM. https://repositorio.ufsm.br/bitstream/handle/1/15824/Lic_Computacao_Metodologia-Pesquisa-Cientifica.pdf?
Ramezani, M., Sahraei, Z., Simani, L., Heydari, K., & Shahidi, F. (2018). Coenzyme Q10 supplementation in acute ischemic stroke: Is it beneficial in short-term administration? Nutritional Neuroscience. https://doi.org/10.1080/1028415X.2018.1541269
Roman, P, Carrillo-Trabalón, F., Sánchez-Labraca, N., Cañadas, F., Estévez, A. F., & Cardona, D. (2018). Are probiotic treatments useful on fibromyalgia syndrome or chronic fatigue syndrome patients? A systematic review. Beneficial Microbes, 9(4), 603–611. https://doi.org/10.3920/BM2017.0125
Roman, Pablo, Estevez, A. F., Miras, A., Sanchez-Labraca, N., Canadas, F., Vivas, A. B., & Cardona, D. (2018). A Pilot Randomized Controlled Trial to Explore Cognitive and Emotional Effects of Probiotics in Fibromyalgia. Scientific Reports, 8(1), 10965. https://doi.org/10.1038/s41598-018-29388-5
Sahota, O. (2014). Understanding vitamin D deficiency. Age and Ageing, 43(5), 589–591. https://doi.org/10.1093/ageing/afu104
Sawaddiruk, P., Apaijai, N., Paiboonworachat, S., Kaewchur, T., Kasitanon, N., Jaiwongkam, T., & Chattipakorn, S. C. (2019). Coenzyme Q10 supplementation alleviates pain in pregabalin-treated fibromyalgia patients via reducing brain activity and mitochondrial dysfunction. Free Radical Research, 53(8), 901–909. https://doi.org/10.1080/10715762.2019.1645955
Shakiba, M., Moazen-Zadeh, E., Noorbala, A. A., Jafarinia, M., Divsalar, P., Kashani, L., & Akhondzadeh, S. (2018). Saffron (Crocus sativus) versus duloxetine for treatment of patients with fibromyalgia: A randomized double-blind clinical trial. Avicenna Journal of Phytomedicine, 8(6), 513–523. Retrieved from https://pubmed.ncbi.nlm.nih.gov/30456199
Slyepchenko, A., Carvalho, A. F., Cha, D. S., Kasper, S., & McIntyre, R. S. (2014). Gut emotions - mechanisms of action of probiotics as novel therapeutic targets for depression and anxiety disorders. CNS & Neurological Disorders Drug Targets, 13(10), 1770–1786. https://doi.org/10.2174/1871527313666141130205242
Stewart, J. A., Mailler-Burch, S., Müller, D., Studer, M., von Känel, R., Grosse Holtforth, M., … Egloff, N. (2019). Rethinking the criteria for fibromyalgia in 2019: the ABC indicators. Journal of Pain Research, 12, 2115–2124. https://doi.org/10.2147/JPR.S205299
Theoharides, T. C., Tsilioni, I., Arbetman, L., Panagiotidou, S., Stewart, J. M., Gleason, R. M., & Russell, I. J. (2015). Fibromyalgia syndrome in need of effective treatments. The Journal of Pharmacology and Experimental Therapeutics, 355(2), 255–263. https://doi.org/10.1124/jpet.115.227298
Wolfe, F., Clauw, D. J., Fitzcharles, M.-A., Goldenberg, D. L., Katz, R. S., Mease, P., & Yunus, M. B. (2010). The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care & Research, 62(5), 600–610. https://doi.org/10.1002/acr.20140
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Jefferson Jovelino Amaral dos Santos; Ana Paula Tardivo; Thaís Cristina Coelho de Ornelas Salazar; Victor Nascimento dos Santos
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
